Compare BLKB & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLKB | SHC |
|---|---|---|
| Founded | 1981 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 4.4B |
| IPO Year | 2004 | 2020 |
| Metric | BLKB | SHC |
|---|---|---|
| Price | $29.60 | $15.96 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $50.00 | $20.33 |
| AVG Volume (30 Days) | 610.0K | ★ 3.9M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 142.32 | 68.75 |
| EPS | ★ 0.67 | 0.09 |
| Revenue | N/A | ★ $1,163,617,000.00 |
| Revenue This Year | $6.26 | $7.51 |
| Revenue Next Year | $4.25 | $6.00 |
| P/E Ratio | ★ $44.05 | $174.39 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $29.33 | $10.80 |
| 52 Week High | $74.86 | $19.85 |
| Indicator | BLKB | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 30.69 | 59.47 |
| Support Level | N/A | $15.18 |
| Resistance Level | $40.38 | $16.48 |
| Average True Range (ATR) | 1.78 | 0.44 |
| MACD | -0.31 | 0.02 |
| Stochastic Oscillator | 8.50 | 83.26 |
Founded in 1981, Blackbaud provides software solutions designed to serve the "social good" community, including nonprofits, foundations, corporations, educational institutions, healthcare institutions, and individual change agents. Through M&A and organic product development efforts, the company has also moved into related areas outside core fundraising, notably into K-12 schools. The firm enables more than $100 billion in donations annually across a customer base in excess of 40,000 customers in over 100 countries.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.